NEW YORK (GenomeWeb) – Indian personalized medicine startup Mitra Biotech announced today that it has raised $27.4 million through a Series B financing round.

Participants in the financing included new investors Sequoia India and Sands Capital Ventures, which co-led the round, and RA Capital Management. Also participating were existing investors Accel and Tata Capital Innovations Fund. In conjunction with the Series B round, Sequoia and Sands will become members of Mitra's board.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

New Mexico is re-doing its proposed science education standards after criticism, the Associated Press reports.

Agbio executives say gene editing will speed up breeding efforts, according to the Wall Street Journal.

La Trobe University's Jenny Graves has won the $250,000 Prime Minister's Prize for Science, the Guardian reports.

In Cell this week: post-treatment changes to melanoma genome, multi-omics analysis of muscle-invasive bladder cancer, and more.

Nov
02
Sponsored by
Qiagen

This webinar will discuss the benefits of using unique molecular indices to overcome some challenges associated with next-generation sequencing panels.

Dec
05
Sponsored by
Agilent Technologies

This webinar will discuss a molecular barcode-based error correction method that enables combined mutation detection and DNA copy number profiling through circulating tumor DNA sequencing.